He is presently the principal investigator at the BWH AIDS Clinical Trials Unit, and is a member of the Cost-Effectiveness of Preventing AIDS Complications (CEPAC) Research Group. Sax’s ongoing areas of research include clinical trials of antiretroviral therapies, cost-effectiveness of management strategies for HIV, and toxicity of antiretroviral therapy. In addition to his clinical and teaching work, Dr. Sax is also on the core faculty of the International AIDS Society - USA and the New England AIDS Education and Training Center. He is Editor-in-Chief of Open Forum Infectious Diseases, is on the Peer Review board of the HIV/AIDS Section of UpToDate, and the editorial advisory board of Medscape HIV/AIDS. Sax is board certified in Internal Medicine and Infectious Diseases. Paul Sax, Calvin Cohen, Daniel Kuritzkes. Paul E Sax, Kristine M Erlandson, Jordan E Lake, Grace A Mccomsey, Chloe Orkin, Stefan Esser, Todd T Brown, Jrgen K Rockstroh, Xuelian Wei, Christoph C Carter, Lijie Zhong, Diana M Brainard, Kathleen Melbourne, Moupali Das, Hans-Jrgen Stellbrink, Frank A Post, Laura Waters, John R Koethe, Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative. He served his residency in Internal Medicine at BWH, while continuing his postdoctoral education with a fellowship in Infectious Diseases at Massachusetts General Hospital. Topics include: HIV diagnosis, evaluation, treatment and prevention Opportunistic infections and other HIV. Sax received his MD from Harvard Medical School. Sax is Clinical Director of the Division of Infectious Diseases and the HIV Program at Brigham and Women's Hospital (BWH), and Professor of Medicine at Harvard Medical School.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
June 2023
Categories |